These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23135838)

  • 21. Structural insights into oxidation of medium-chain fatty acids and flavanone by myxobacterial cytochrome P450 CYP267B1.
    Jóźwik IK; Litzenburger M; Khatri Y; Schifrin A; Girhard M; Urlacher V; Thunnissen AWH; Bernhardt R
    Biochem J; 2018 Sep; 475(17):2801-2817. PubMed ID: 30045877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
    Murataliev MB; Feyereisen R
    Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of cytochrome P450 CYP105N1 from Streptomyces coelicolor, an oxidase in the coelibactin siderophore biosynthetic pathway.
    Lim YR; Hong MK; Kim JK; Doan TT; Kim DH; Yun CH; Chun YJ; Kang LW; Kim D
    Arch Biochem Biophys; 2012 Dec; 528(2):111-7. PubMed ID: 23000034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular dynamics simulations of P450 BM3--examination of substrate-induced conformational change.
    Chang YT; Loew GH
    J Biomol Struct Dyn; 1999 Jun; 16(6):1189-203. PubMed ID: 10447203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuning the regio- and stereoselectivity of C-H activation in n-octanes by cytochrome P450 BM-3 with fluorine substituents: evidence for interactions between a C-F bond and aromatic π systems.
    Wu LL; Yang CL; Lo FC; Chiang CH; Chang CW; Ng KY; Chou HH; Hung HY; Chan SI; Yu SS
    Chemistry; 2011 Apr; 17(17):4774-87. PubMed ID: 21400620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. To Be, or Not to Be, an Inhibitor: A Comparison of Azole Interactions with and Oxidation by a Cytochrome P450 Enzyme.
    Podgorski MN; Coleman T; Giang PD; Wang CR; Bruning JB; Bernhardt PV; De Voss JJ; Bell SG
    Inorg Chem; 2022 Jan; 61(1):236-245. PubMed ID: 34910500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetically and Crystallographically Guided Mutations of a Benzoate CoA Ligase (BadA) Elucidate Mechanism and Expand Substrate Permissivity.
    Thornburg CK; Wortas-Strom S; Nosrati M; Geiger JH; Walker KD
    Biochemistry; 2015 Oct; 54(40):6230-42. PubMed ID: 26378464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for the properties of two single-site proline mutants of CYP102A1 (P450BM3).
    Whitehouse CJ; Yang W; Yorke JA; Rowlatt BC; Strong AJ; Blanford CF; Bell SG; Bartlam M; Wong LL; Rao Z
    Chembiochem; 2010 Dec; 11(18):2549-56. PubMed ID: 21110374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate recognition by the multifunctional cytochrome P450 MycG in mycinamicin hydroxylation and epoxidation reactions.
    Li S; Tietz DR; Rutaganira FU; Kells PM; Anzai Y; Kato F; Pochapsky TC; Sherman DH; Podust LM
    J Biol Chem; 2012 Nov; 287(45):37880-90. PubMed ID: 22952225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-directed mutagenesis of the putative distal helix of peroxygenase cytochrome P450.
    Matsunaga I; Ueda A; Sumimoto T; Ichihara K; Ayata M; Ogura H
    Arch Biochem Biophys; 2001 Oct; 394(1):45-53. PubMed ID: 11566026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substrate recognition and molecular mechanism of fatty acid hydroxylation by cytochrome P450 from Bacillus subtilis. Crystallographic, spectroscopic, and mutational studies.
    Lee DS; Yamada A; Sugimoto H; Matsunaga I; Ogura H; Ichihara K; Adachi S; Park SY; Shiro Y
    J Biol Chem; 2003 Mar; 278(11):9761-7. PubMed ID: 12519760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant.
    Whitehouse CJ; Yang W; Yorke JA; Tufton HG; Ogilvie LC; Bell SG; Zhou W; Bartlam M; Rao Z; Wong LL
    Dalton Trans; 2011 Oct; 40(40):10383-96. PubMed ID: 21603690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different binding modes of two flaviolin substrate molecules in cytochrome P450 158A1 (CYP158A1) compared to CYP158A2.
    Zhao B; Lamb DC; Lei L; Kelly SL; Yuan H; Hachey DL; Waterman MR
    Biochemistry; 2007 Jul; 46(30):8725-33. PubMed ID: 17614370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The substrate binding site of human liver cytochrome P450 2C9: an NMR study.
    Poli-Scaife S; Attias R; Dansette PM; Mansuy D
    Biochemistry; 1997 Oct; 36(42):12672-82. PubMed ID: 9335524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrophobic side chain requirements for lauric acid and progesterone hydroxylation at amino acid 113 in cytochrome P450 2C2, a potential determinant of substrate specificity.
    Straub P; Johnson EF; Kemper B
    Arch Biochem Biophys; 1993 Nov; 306(2):521-7. PubMed ID: 8215458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification, crystallization and preliminary crystallographic analysis of cytochrome P450 203A1 from Rhodopseudomonas palustris.
    Pang X; Xu F; Bell SG; Guo D; Wong LL; Rao Z
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Apr; 63(Pt 4):342-5. PubMed ID: 17401212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of substrates at the surface of P450s can greatly enhance substrate potency.
    Hegde A; Haines DC; Bondlela M; Chen B; Schaffer N; Tomchick DR; Machius M; Nguyen H; Chowdhary PK; Stewart L; Lopez C; Peterson JA
    Biochemistry; 2007 Dec; 46(49):14010-7. PubMed ID: 18004886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
    Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
    J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
    Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.